Redwood City, CA, United States of America

Nicole Peck

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Inventor Nicole Peck: Pioneering ROS-responsive Liposomes

Introduction: Nicole Peck is a prominent inventor based in Redwood City, California, known for her groundbreaking work in pharmaceuticals and nanotechnology. With a total of five patents to her name, Peck is making significant contributions to the field, particularly through her latest innovations involving reactive oxygen species (ROS) and targeted drug delivery systems.

Latest Patents: Among her noteworthy inventions, Nicole Peck's latest patent involves the development of ROS-responsive liposomes specifically designed for targeted therapy. The invention features encapsulated liposomes that comprise a lipid bilayer, a first polyethylene glycol (PEG) corona, a targeting molecule, and a second PEG corona. Notably, the second encapsulating PEG corona can be reversibly linked to the first PEG corona, enhancing the functionality and efficiency of drug delivery. This patented technology aims to treat diseases characterized by the production of reactive oxygen species (ROS), offering new avenues for effective therapeutic interventions.

Career Highlights: Nicole Peck has built her career at Verily Life Sciences LLC, where she applies her expertise in the life sciences sector. Her innovative approach to addressing complex medical challenges through advanced technologies and therapies has garnered recognition within the scientific community.

Collaborations: Throughout her career, Nicole Peck has worked alongside talented individuals such as Zhan Wang and Stephen Morton, contributing to a collaborative environment that fosters innovation and scientific advancement. Together, they are pushing the boundaries of research on targeted therapies and drug formulations.

Conclusion: With her impressive portfolio of patents and her role at Verily Life Sciences LLC, Nicole Peck stands out as a leading figure in pharmaceutical innovation. Her latest work on ROS-responsive liposomes not only reflects her dedication to advancing medical treatments but also highlights the importance of targeted drug delivery systems in contemporary healthcare solutions. As she continues to explore new frontiers in her field, Nicole Peck is sure to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…